Stefan Schülke - Search Results

Year	Number of Results
2010	1
2011	1
2012	1
2014	2
2015	2
2016	3
2017	3
2018	7
2019	6
2020	1
2021	6

1

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.

Lin YJ, Anzaghe M, Schülke S. Lin YJ, et al. Among authors: schulke s. Cells. 2020 Apr 3;9(4):880. doi: 10.3390/cells9040880. Cells. 2020. PMID: 32260219 Free PMC article. Review.

2

Mouse Models for Food Allergies: Where Do We Stand?

Schülke S, Albrecht M. Schülke S, et al. Cells. 2019 Jun 6;8(6):546. doi: 10.3390/cells8060546. Cells. 2019. PMID: 31174293 Free PMC article. Review.

3

[Immunological background and pathomechanisms of food allergies].

Schülke S, Scheurer S. Schülke S, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jun;59(6):723-31. doi: 10.1007/s00103-016-2346-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016. PMID: 27177897 Review. German.

4

Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies.

Blanco-Pérez F, Papp G, Goretzki A, Möller T, Anzaghe M, Schülke S. Blanco-Pérez F, et al. Among authors: schulke s. Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):273-293. doi: 10.1007/s00005-019-00551-8. Epub 2019 Jun 20. Arch Immunol Ther Exp (Warsz). 2019. PMID: 31222414 Review.

5

Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy.

Anzaghe M, Schülke S, Scheurer S. Anzaghe M, et al. Among authors: schulke s. Curr Allergy Asthma Rep. 2018 Oct 25;18(12):71. doi: 10.1007/s11882-018-0827-1. Curr Allergy Asthma Rep. 2018. PMID: 30362017 Review.

6

A Model for Apoptotic-Cell-Mediated Adaptive Immune Evasion via CD80-CTLA-4 Signaling.

Yakoub AM, Schülke S. Yakoub AM, et al. Among authors: schulke s. Front Pharmacol. 2019 May 31;10:562. doi: 10.3389/fphar.2019.00562. eCollection 2019. Front Pharmacol. 2019. PMID: 31214024 Free PMC article.

7

Interaction of Non-Specific Lipid-Transfer Proteins With Plant-Derived Lipids and Its Impact on Allergic Sensitization.

Scheurer S, Schülke S. Scheurer S, et al. Among authors: schulke s. Front Immunol. 2018 Jun 20;9:1389. doi: 10.3389/fimmu.2018.01389. eCollection 2018. Front Immunol. 2018. PMID: 29973934 Free PMC article. Review.

8

Dendritic cell targeting with C-type lectins for improvement of allergen immunotherapy.

Schülke S, Vieths S. Schülke S, et al. J Allergy Clin Immunol. 2016 Aug;138(2):568-70. doi: 10.1016/j.jaci.2016.06.006. Epub 2016 Jun 23. J Allergy Clin Immunol. 2016. PMID: 27497282 No abstract available.

9

Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.

Schülke S. Schülke S. Front Immunol. 2018 Mar 19;9:455. doi: 10.3389/fimmu.2018.00455. eCollection 2018. Front Immunol. 2018. PMID: 29616018 Free PMC article. Review.

10

The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling.

Blanco-Pérez F, Goretzki A, Wolfheimer S, Schülke S. Blanco-Pérez F, et al. Among authors: schulke s. Mol Immunol. 2019 Feb;106:159-169. doi: 10.1016/j.molimm.2018.12.029. Epub 2019 Jan 9. Mol Immunol. 2019. PMID: 30623816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results